On September 11-13, 2026, the 23rd Academic Meeting of the Neurosurgery Branch of the Chinese Medical Association was grandly held at the Dalian International Convention Center in Liaoning. The conference was hosted by the Chinese Medical Association and the Neurosurgery Branch of the Chinese Medical Association, and organized by Shengjing Hospital affiliated to China Medical University. It gathered more than 3,000 experts and scholars in the field of neurosurgery from across the country to conduct in-depth discussions on the frontiers of the discipline, clinical technology innovation, and the development of minimally invasive diagnosis and treatment, jointly exploring new paths for the high-quality development of neurosurgery in China. As a high-tech and specialized enterprise deeply engaged in the field of minimally invasive medical devices for neurosurgery, Jilin Laiwo Medical Technology Co., Ltd. participated in the conference with a series of innovative neurosurgery products, engaging in academic exchanges with domestic neurosurgeons and discussing new directions for the clinical application and development of minimally invasive technology.

This conference focuses on hot topics such as brain tumors, cerebrovascular diseases, neuroendoscopy, and craniocerebral trauma. Through diverse forms such as keynote speeches, symposiums, surgical video demonstrations, and poster exchanges, it fully showcases the latest research achievements and clinical practical experiences in the field of neurosurgery in China, establishing a high-level and multi-tiered academic exchange platform. The conference advocates for the deep integration of basic research and clinical practice, promotes the popularization and implementation of minimally invasive and precise diagnostic and treatment technologies, and provides a rich academic feast for a wide range of clinicians.

At the conference, the LAIWO Medical booth attracted numerous experts and clinicians for visits and exchanges. This exhibition focused on showcasing core neurosurgical products such as disposable brain retractors, disposable incision protectors, and disposable sterile controllable suction catheters. Additionally, it presented post-operative wound care products like wound repair series bio-colloid dispersants and algal bio-colloids, presenting a comprehensive clinical solution from intraoperative surgical instruments to post-operative wound repair.

Among them, the disposable brain retraction guide catheter, as a representative innovative product of the company, is specifically designed for intracranial deep lesion surgeries. It can establish a safe and stable surgical pathway, reduce brain tissue traction damage, and better adapt to neuroendoscopic and microsurgical scenarios, facilitating the development of neurosurgery towards a more minimally invasive and safer direction. It received significant attention and discussion from the experts present. The on-site technical team engaged in in-depth communication with clinical experts, focusing on product usage experience and clinical optimization directions, while considering the practical pain points of clinical procedures. They listened to valuable feedback and suggestions from frontline physicians.

Leveraging the collaborative innovation strengths of industry, academia, and research, Laiwo Medical continuously conducts product research and development based on real clinical needs. Adhering to the R&D approach of "frontline physicians + clinical needs + innovative products", multiple products have filled the gap in the domestic market for similar products, and the products have now covered hundreds of medical institutions across the country.

Over the years, Laiwo Medical has been continuously deepening its expertise in the neurosurgery field, adhering to independent innovation and guided by clinical value, refining its medical device products, and committed to providing safe and reliable domestic device options for neurosurgery clinics. The relevant person in charge of the company stated that in the future, Laiwo Medical will continue to strengthen technological research, deepen the integration of medicine and engineering, actively promote the transformation and implementation of more innovative medical device achievements, contribute to the advancement of minimally invasive neurosurgery technology in China, and contribute the strength of a national medical device enterprise to safeguarding the brain health of the nation's citizens.